Suppliers / Savior Lifetec

Savior Lifetec

Taiwan Updated 9 July 2026

Savior Lifetec is a contract manufacturer based in Taiwan. It holds 4 active US drug master files across a filed portfolio of 4 molecules. Its filings concentrate with MINSA (CR), ARCSA (EC) and NMPA (CN). Its GMP standing is certified by EMA, US FDA and ANVISA (Brazil), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 23 October 2025 as VAI.

4
active US DMFs
0
valid CEPs
6
registered plants 1 with an FDA FEI number
6
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 23 October 2025 VAI US FDA
  • 29 November 2022 VAI US FDA
  • 26 October 2018 VAI US FDA
  • 22 April 2016 VAI US FDA
  • 16 May 2014 NAI US FDA
  • 13 May 2011 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
MIAOLI, Taiwan Not on file
MIAOLI COUNTY, Taiwan Not on file
TAINAN, Taiwan Not on file
Tainan City, Taiwan Not on file
Tainan City, Taiwan Not on file
Taiwan, Taiwan 3005840211

What they file, and where

Molecule Regulators Docs
Imipenem SFDA (Saudi Arabia), US FDA 3
Cilastatin SFDA (Saudi Arabia), US FDA 2
Meropenem SFDA (Saudi Arabia), US FDA 2
Ertapenem SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Ertapenem contract manufacturing Meropenem contract manufacturing Prucalopride contract manufacturing

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 3 None
ARCSA (EC) 2 None
NMPA (CN) 1 None
EMA None 4
US FDA None 1
ANVISA (Brazil) None 1
MHRA (UK) None 1

Comparing suppliers?

Choose your molecules and target markets. Savior Lifetec comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 23 October 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates